Prognostic and Diagnostic Value of Endocan in Kidney Diseases
- PMID: 35321346
- PMCID: PMC8938144
- DOI: 10.1155/2022/3861092
Prognostic and Diagnostic Value of Endocan in Kidney Diseases
Abstract
Endocan, previously called endothelial cell-specific molecule-1, is a soluble proteoglycan that is predominantly expressed in vascular endothelial cells of the lungs and kidneys. It is upregulated by proinflammatory cytokines and plays a critical role in inflammatory, proliferative, and neovascularization processes. The utility of endocan as a biomarker in a wide spectrum of diseases is being increasingly acknowledged. In this review, we summarize the current evidence concerning the role of endocan in kidney diseases, with emphasis on its prognostic and diagnostic value. It seems that the determination of plasma endocan levels may provide useful prognostic information in many types of renal failure such as chronic kidney disease, IgA nephropathy, and diabetic nephropathy. Endocan could additionally improve the early diagnostic evaluation of acute kidney disease, chronic renal allograft injury, and acute rejection after kidney transplantation, thus contributing to endothelial cell injury monitoring in a timely manner.
Copyright © 2022 Elisabeth Samouilidou et al.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures
Similar articles
-
Endocan: A novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases.Clin Chim Acta. 2020 Oct;509:310-335. doi: 10.1016/j.cca.2020.07.041. Epub 2020 Jul 22. Clin Chim Acta. 2020. PMID: 32710940 Review.
-
The Role of Endocan in Selected Kidney Diseases.Int J Mol Sci. 2020 Aug 25;21(17):6119. doi: 10.3390/ijms21176119. Int J Mol Sci. 2020. PMID: 32854332 Free PMC article. Review.
-
Plasma endocan level and prognosis of immunoglobulin A nephropathy.Kidney Res Clin Pract. 2016 Sep;35(3):152-9. doi: 10.1016/j.krcp.2016.07.001. Epub 2016 Jul 14. Kidney Res Clin Pract. 2016. PMID: 27668158 Free PMC article.
-
The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.Curr Eye Res. 2015 Mar;40(3):321-31. doi: 10.3109/02713683.2014.921312. Epub 2014 May 28. Curr Eye Res. 2015. PMID: 24871583
-
Endocan: A Key Player of Cardiovascular Disease.Front Cardiovasc Med. 2022 Jan 5;8:798699. doi: 10.3389/fcvm.2021.798699. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35071362 Free PMC article. Review.
Cited by
-
Endocan as a Potential Marker for Predicting All-Cause Mortality in Hemodialysis Patients.J Clin Med. 2023 Nov 30;12(23):7427. doi: 10.3390/jcm12237427. J Clin Med. 2023. PMID: 38068479 Free PMC article.
-
New potential biomarkers for early chronic kidney disease diagnosis in patients with different glucose tolerance status.Front Endocrinol (Lausanne). 2023 Jul 6;14:1206336. doi: 10.3389/fendo.2023.1206336. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37484969 Free PMC article.
-
Endothelial injury and inflammation in patients with hyperuricemic nephropathy at chronic kidney disease stages 1-2 and 3-4.World J Clin Cases. 2022 Nov 16;10(32):11766-11774. doi: 10.12998/wjcc.v10.i32.11766. World J Clin Cases. 2022. PMID: 36405284 Free PMC article. Clinical Trial.
-
Serum Endocan as a Predictor of Survival and Cardiovascular Events in Patients Without Diabetic Kidney Disease on Chronic Haemodialysis: A Prospective, Observational Study.Medicina (Kaunas). 2025 May 27;61(6):991. doi: 10.3390/medicina61060991. Medicina (Kaunas). 2025. PMID: 40572679 Free PMC article.
-
Clinical significance of urinary inflammatory biomarkers in patients with IgA nephropathy.BMC Nephrol. 2024 Apr 22;25(1):142. doi: 10.1186/s12882-024-03574-2. BMC Nephrol. 2024. PMID: 38649936 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous